Skip to main content
Richard Whitley, MD, Pediatric Infectious Disease, Birmingham, AL, Children's of Alabama

RichardJWhitleyMD

Pediatric Infectious Disease Birmingham, AL

Professor, Pediatrics, University of Alabama School of Medicine

Dr. Whitley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Whitley's full profile

Already have an account?

Summary

  • Distinguished Professor of Pediatrics

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Pediatrics, 1971 - 1975
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1971

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1973 - 2024
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1989
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • IDBR Infectious Disease Board Review Course 
    George Washington University, Mclean, Virginia - 8/24/2013

Press Mentions

  • Altesa BioSciences Announces Scientific Advisory Board
    Altesa BioSciences Announces Scientific Advisory BoardFebruary 28th, 2022
  • Merck's COVID Pill Shows 'Modest' Benefit in High-Risk Outpatients
    Merck's COVID Pill Shows 'Modest' Benefit in High-Risk OutpatientsDecember 16th, 2021
  • There Are Few Good COVID Antivirals, but That Could Be Changing
    There Are Few Good COVID Antivirals, but That Could Be ChangingJuly 15th, 2021
  • Join now to see all

Grant Support

  • Preclinical Evaluation Of Oncolytic HSV For Anaplastic Glioma TherapyNational Cancer Institute2009–2011
  • Engineered HSV For Treatment Of Malignant GliomaNational Cancer Institute2009–2011
  • Administrative CoreNational Cancer Institute2009–2011
  • Development Of Antiviral Screens And Animal ModelsNational Institute Of Allergy And Infectious Diseases2008
  • Engineered HSV For Treatment Of Malignant GliomasNational Cancer Institute2003–2007
  • High Dose Acyclovir Versus Vidarabine In Neonatal Herpes Simplex InfectionNational Center For Research Resources1998–2002
  • Ganciclovir (DHPG) For Symptomatic Congenital Cytomegalovirus InfectionsNational Center For Research Resources1997–2002
  • Engineered Herpes Simplex Virus For Treatment Of GliomasNational Cancer Institute1997–2001
  • Biologic Characterization Of Engineered HSV For Therapy Of Brain TumorsNational Cancer Institute1997–2001
  • PDL MSL 109 In Infants With NON CNS Symptomatic Congenital CMV InfectionsNational Center For Research Resources1998–2000
  • Clinical Studies Of Therapies For Virus InfectionsNational Institute Of Allergy And Infectious Diseases1996–2000
  • Recurrent Skin Vesicles Following Neonatal HSV Of The Skin, Eye &MouthNational Center For Research Resources1998–1999
  • Core--ClinicalNational Institute Of Allergy And Infectious Diseases1997
  • High Dose Ganciclovir(Dhpg) For Symptomatic Congenital Cytomegalovirus InfectionNational Center For Research Resources1997
  • In Vivo Animal Model Evaluation Of Candidate VaccinesNational Institute Of Allergy And Infectious Diseases1992–1995
  • Sixth International Conference On Antiviral ResearchNational Institute Of Allergy And Infectious Diseases1993
  • Fifth International Conference On Antiviral ResearchNational Institute Of Allergy And Infectious Diseases1992
  • Fourth International Conference On Antiviral ResearchNational Institute Of Allergy And Infectious Diseases1991
  • Birmingham NcddgNational Institute Of Allergy And Infectious Diseases1987–1991
  • Third International Conference On Antiviral ResearchNational Institute Of Allergy And Infectious Diseases1990
  • Trial On Antivirals For Severe Herpes Virus InfectionsNational Institute Of Allergy And Infectious Diseases1986–1990
  • Trial On Antivirals For Severe Herpesvirus InfectionsNational Institute Of Allergy And Infectious Diseases1986
  • Efficacy Trials Of Antivirals For Severe Herpes VirusNational Institute Of Allergy And Infectious Diseases1985–1986

Professional Memberships

Hospital Affiliations